Michael Wiederhorn Analyst PerformanceManaging Director at OppenheimerMichael Wiederhorn is a stock analyst at Oppenheimer focused in the medical sector, covering 18 publicly traded companies. Over the past year, Michael Wiederhorn has issued 22 stock ratings, including buy and hold recommendations. While full access to Michael Wiederhorn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Wiederhorn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings112 Last 11 YearsBuy Recommendations95.33% 102 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution107RatingsDistribution of strong buy, buy, hold, and sell ratings by Michael Wiederhorn.RatingPercentageCount Strong Buy0.0%0 ratings Buy95.3%102 ratings Hold4.7%5 ratings Sell0.0%0 ratingsOut of 107 total stock ratings issued by Michael Wiederhorn at Oppenheimer, the majority (95.3%) have been Buy recommendations, followed by 4.7% Hold.Best & Worst CallsBest Call0000.0%CNCFeb 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CYHJun 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE77.8% of companies on NYSE14 companiesNASDAQ22.2% of companies on NASDAQ4 companiesMichael Wiederhorn, an analyst at Oppenheimer, currently covers 18 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical16 companies88.9%Computer and Technology1 company5.6%Business Services1 company5.6%Michael Wiederhorn of Oppenheimer specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Business Services companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES5 companies27.8%MED - HMO4 companies22.2%MED - OUTP/HM CRE3 companies16.7%MED - HOSPITALS2 companies11.1%MED - DRUGS1 company5.6%INTERNET SOFTWARE1 company5.6%MED - NURSING HMS1 company5.6%STAFFING1 company5.6% About Michael WiederhornMichael Wiederhorn is Managing Director and Senior Analyst covering Healthcare Providers and Services. His coverage focuses on managed care, hospitals, nursing homes, home health, hospice, emergency services, and related healthcare services. He has over fifteen years of experience in healthcare consulting and research and in 2013, he was honored as a top ranked Earnings Estimator in Health Care Providers & Services 2013 by Financial Times/Starmine. In addition, in 2009 and 2010, Michael was ranked the #1 brokerage analyst for Medical Care by Forbes Magazine. Prior to entering equity research, Michael was a management consultant at Ernst and Young, serving the healthcare industry. He has a Masters in Health Policy and Management from Harvard University and BA in American History from the University of Pennsylvania.Follow on LinkedIn Michael Wiederhorn's Ratings History at Oppenheimer Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPACSPACS Group5/13/2026Boost Price Target$41.04$48.00Outperform$0.0000.00% ROIGRDNGuardian Pharmacy Services5/7/2026Boost Price Target$36.60$43.00Outperform$0.0000.00% ROICNCCentene4/29/2026Reiterated Rating$49.42$58.00Outperform$0.0000.00% ROIHCAHCA Healthcare4/27/2026Lower Price Target$439.46$520.00Outperform$0.0000.00% ROIUNHUnitedHealth Group4/22/2026Boost Price Target$355.42$405.00Outperform$0.0000.00% ROIGRDNGuardian Pharmacy Services3/12/2026Boost Price Target$35.10$38.00Outperform$0.0000.00% ROIPACSPACS Group3/4/2026Boost Price Target$36.75$42.00Outperform$0.0000.00% ROITDOCTeladoc Health3/3/2026Lower Price Target$5.17$7.00Outperform$0.0000.00% ROIEVHEvolent Health3/2/2026Lower Price Target$3.32$6.00Outperform$0.0000.00% ROICHEChemed2/27/2026Lower Price Target$397.57$500.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. EHABEnhabit2/23/2026Downgrade$13.60Market Perform$0.0000.00% ROIHCAHCA Healthcare1/28/2026Boost Price Target$506.29$540.00Outperform$0.0000.00% ROIUNHUnitedHealth Group1/28/2026Lower Price Target$293.53$385.00Outperform$0.0000.00% ROIEHABEnhabit1/22/2026Upgrade$10.72$14.00Outperform$0.0000.00% ROIEVHEvolent Health11/12/2025Lower Price Target$4.79$12.00Outperform$0.0000.00% ROICNCCentene10/30/2025Reiterated Rating$36.70$45.00Outperform$0.0000.00% ROIHCAHCA Healthcare10/27/2025Boost Price Target$446.58$500.00Outperform$0.0000.00% ROIGRDNGuardian Pharmacy Services10/10/2025Initiated Coverage$23.68$30.00Outperform$0.0000.00% ROICHEChemed7/31/2025Lower Price Target$416.31$580.00Outperform$0.0000.00% ROIUNHUnitedHealth Group7/30/2025Lower Price Target$260.85$325.00Outperform$0.0000.00% ROICNCCentene7/28/2025Lower Price Target$27.70$43.00Outperform$0.0000.00% ROICNCCentene7/15/2025Lower Price Target$30.37$51.00Outperform$0.0000.00% ROIUNHUnitedHealth Group5/14/2025Lower Price Target$314.38$400.00Outperform$000.0000.00% ROIHUMHumana5/1/2025Boost Price Target$259.54$310.00Outperform$000.0000.00% ROIUNHUnitedHealth Group4/21/2025Lower Price Target$456.10$600.00Outperform$000.0000.00% ROICICigna Group1/31/2025Lower Price Target$296.88$375.00Outperform$000.0000.00% ROITDOCTeladoc Health1/24/2025Lower Price Target$10.22$12.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageMorgan StanleyJefferies Financial GroupStifel NicolausOppenheimerBerenberg BankRoth MkmWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD Cowen Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
